Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG) (Journal article)

Papaxoinis, G./ Fountzilas, G./ Rontogianni, D./ Dimopoulos, M. A./ Pavlidis, N./ Tsatalas, C./ Pectasides, D./ Xiros, N./ Economopoulos, T.

BACKGROUND: The aim was to examine characteristics and treatment results of patients with mucosa-associated lymphoid tissue (MALT) non-Hodgkin's lymphomas. PATIENTS AND METHODS: Epidemiological and clinical features of 97 patients with MALT lymphoma from the Hellenic Cooperative Oncology Group registry were analysed retrospectively for their prognostic significance in progression-free survival (PFS) and overall survival (OS). Comparisons were made between patients with gastric and nongastric sites of primary lymphoma and between different therapeutic modalities. RESULTS: Sixty-five patients presented with gastric and 32 with nongastric lymphomas. The most frequent locations of nongastric lymphomas were the bowel, lung and parotid. Gastric lymphomas occurred more frequently in males and younger patients compared with nongastric lymphomas. Seventy-four per cent of patients had early (Ann Arbor stages I-II) and 26% had advanced (stages III-IV) disease. The median PFS for the entire population was 44 months. At 5 years, 47% of patients were progression free and the OS rate was 80%. The most reliable prognostic factor for PFS and OS was the Ann Arbor stage; 5-year PFS was 67% versus 13% and 5-year OS 91% versus 51% for patients with early versus advanced disease, respectively (P < 0.001). Of the patients treated with chemotherapy only, 87% achieved an objective response and 71% complete response. Surgery did not offer survival benefit compared with chemotherapy in localised gastric lymphoma. CONCLUSION: MALT lymphomas represent a distinct disease entity with widespread extranodal origin, indolent clinical course and high chemosensitivity. Ann Arbor stage was the most reliable prognostic and predictive factor.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adolescent,Adult,Aged,Aged, 80 and over,Analysis of Variance,Chemotherapy, Adjuvant,Disease-Free Survival,Female,Greece/epidemiology,Humans,Kaplan-Meier Estimate,Lung Neoplasms/diagnosis/therapy,Lymphoma, B-Cell, Marginal Zone/*diagnosis/drug,therapy/epidemiology/pathology/surgery/*therapy,Male,Middle Aged,Neoplasm Staging,Parotid Neoplasms/diagnosis/therapy,Prognosis,Proportional Hazards Models,Registries,Retrospective Studies,Risk Factors,Severity of Illness Index,Stomach Neoplasms/diagnosis/therapy
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20293
ISSN: 1569-8041
Link: http://www.ncbi.nlm.nih.gov/pubmed/18156143
http://annonc.oxfordjournals.org/content/19/4/780.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Papaxoinis-2008-Low-grade mucosa-ass.pdf167.2 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20293
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.